149 related articles for article (PubMed ID: 32731184)
1. Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancer.
Zhou Y; Xu X; Wang F; He H; Gong G; Xiong L; Qi B
Eur J Med Chem; 2020 Oct; 204():112643. PubMed ID: 32731184
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer.
Zhou Y; Xu X; Wang F; He H; Qi B
Bioorg Chem; 2021 Jan; 106():104511. PubMed ID: 33272707
[TBL] [Abstract][Full Text] [Related]
3. Identification of (S)-1-(2-(2,4-difluorophenyl)-4-oxothiazolidin-3-yl)-3-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)urea as a potential anti-colorectal cancer agent.
Qi B; Wang F; He H; Fan M; Hu L; Xiong L; Gong G; Shi S; Song X
Eur J Med Chem; 2022 Sep; 239():114561. PubMed ID: 35763868
[TBL] [Abstract][Full Text] [Related]
4. Discovery of N
Qi B; Yang Y; Gong G; He H; Yue X; Xu X; Hu Y; Li J; Chen T; Wan X; Zhang A; Zhou G
Eur J Med Chem; 2019 Feb; 163():10-27. PubMed ID: 30503936
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.
Nan X; Li HJ; Fang SB; Li QY; Wu YC
Eur J Med Chem; 2020 May; 193():112241. PubMed ID: 32200199
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM
Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel N
Qi B; Yang Y; He H; Yue X; Zhou Y; Zhou X; Chen Y; Liu M; Zhang A; Wei F
Eur J Med Chem; 2018 Feb; 146():368-380. PubMed ID: 29407963
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors.
Liu M; Hou Y; Yin W; Zhou S; Qian P; Guo Z; Xu L; Zhao Y
Eur J Med Chem; 2016 Aug; 119():96-108. PubMed ID: 27155466
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).
Shaheen MA; El-Emam AA; El-Gohary NS
Bioorg Chem; 2020 Dec; 105():104274. PubMed ID: 33339080
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors.
Li S; Zhao Y; Wang K; Gao Y; Han J; Cui B; Gong P
Bioorg Med Chem; 2013 Jun; 21(11):2843-55. PubMed ID: 23628470
[TBL] [Abstract][Full Text] [Related]
13. Discovery andw biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors.
Zhou S; Liao H; Liu M; Feng G; Fu B; Li R; Cheng M; Zhao Y; Gong P
Bioorg Med Chem; 2014 Nov; 22(22):6438-52. PubMed ID: 25438768
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel conjugates of quinoline and thiazolidinone urea as potential anti-colorectal cancer agent.
Xiong L; He H; Fan M; Hu L; Wang F; Song X; Shi S; Qi B
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2334-2347. PubMed ID: 36043496
[TBL] [Abstract][Full Text] [Related]
15. Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors.
Liao W; Hu G; Guo Z; Sun D; Zhang L; Bu Y; Li Y; Liu Y; Gong P
Bioorg Med Chem; 2015 Aug; 23(15):4410-4422. PubMed ID: 26169763
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.
El-Gamal MI; Khan MA; Tarazi H; Abdel-Maksoud MS; Gamal El-Din MM; Yoo KH; Oh CH
Eur J Med Chem; 2017 Feb; 127():413-423. PubMed ID: 28088086
[TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of novel 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazones as c-Met kinase inhibitors.
Qi B; Mi B; Zhai X; Xu Z; Zhang X; Tian Z; Gong P
Bioorg Med Chem; 2013 Sep; 21(17):5246-60. PubMed ID: 23838381
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity.
Zaraei SO; Al-Ach NN; Anbar HS; El-Gamal R; Tarazi H; Tokatly RT; Kalla RR; Munther MA; Wahba MM; Alshihabi AM; Shehata MK; Sbenati RM; Shahin AI; El-Awady R; Al-Tel TH; El-Gamal MI
Eur J Med Chem; 2022 Aug; 238():114434. PubMed ID: 35551038
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 4-(3,5-dimethoxy-4-(((4-methoxyphenethyl)amino)methyl)phenoxy)-N-phenylaniline as a novel c-myc inhibitor against colorectal cancer in vitro and in vivo.
Yang J; Cao C; Luo D; Lan S; Luo M; Shan H; Ma X; Liu Y; Yu S; Zhong X; Li R
Eur J Med Chem; 2020 Jul; 198():112336. PubMed ID: 32387836
[TBL] [Abstract][Full Text] [Related]
20. Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases.
Shin SY; Yoon H; Hwang D; Ahn S; Kim DW; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2013 Nov; 21(22):7018-24. PubMed ID: 24095020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
